ASLIHAN YURDAOZ: Open Payments
NPI 1437691086 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,212 in 22 payments from 11 companies in 2025. Trend: 2023 $933 · 2024 $1,893 · 2025 $1,212
Food & beverage: $1,212
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 5 | $272 |
| ABIOMED | 5 | $226 |
| AstraZeneca Pharmaceuticals LP | 3 | $160 |
| Boston Scientific Corporation | 1 | $153 |
| Regeneron Healthcare Solutions, Inc. | 1 | $135 |
| Lilly USA, LLC | 1 | $104 |
| Amgen Inc. | 1 | $60 |
| BridgeBio Pharma, Inc. | 2 | $35 |
| CVRx, Inc. | 1 | $31 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
Products named: SAPIEN 3 Ultra RESILIA, WATCHMAN, FARXIGA, EVKEEZA, ZEPBOUND, Repatha, EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV), Attruby.
Industry payments across NY — which companies pay providers there.
